Anhui Huangshan Capsule Co., Ltd. (SHE:002817)
8.08
+0.06 (0.75%)
Oct 24, 2025, 9:45 AM CST
Anhui Huangshan Capsule Revenue
Anhui Huangshan Capsule had revenue of 124.84M CNY in the quarter ending June 30, 2025, with 6.83% growth. This brings the company's revenue in the last twelve months to 482.10M, up 8.98% year-over-year. In the year 2024, Anhui Huangshan Capsule had annual revenue of 473.48M with 2.31% growth.
Revenue (ttm)
482.10M
Revenue Growth
+8.98%
P/S Ratio
4.98
Revenue / Employee
707.92K
Employees
681
Market Cap
2.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 473.48M | 10.71M | 2.31% |
| Jan 1, 2024 | 462.77M | 34.45M | 8.04% |
| Jan 1, 2023 | 428.32M | 48.43M | 12.75% |
| Dec 31, 2021 | 379.89M | 60.46M | 18.93% |
| Dec 31, 2020 | 319.43M | -6.13M | -1.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 42.62B |
| WuXi AppTec | 41.90B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |
| Shanghai Fosun Pharmaceutical (Group) | 40.12B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Jiangsu Hengrui Medicine | 30.15B |
| Zhejiang NHU Company | 22.87B |
| Aier Eye Hospital Group | 21.94B |